ENZN Projected Dividend Yield
Enzon Pharmaceuticals Inc ( OTCBB : ENZN )Enzon Pharmaceuticals is engaged in licensing arrangements with other companies primarily related to sales of certain drug products that utilize Co.'s proprietary technology. Co. has a marketing agreement relating to the drug Vicineum. Vicineum, a drug being developed by Sesen, Inc., is approved for the treatment of non-muscle invasive bladder cancer. 22 YEAR PERFORMANCE RESULTS |
ENZN Dividend History Detail ENZN Dividend News ENZN Competitors News |
Year | Declaration Date | Ex-Dividend Date | Record Date | Payable Date | Dividend $ Amount |
2019 | Aug 22, 2019 | Sep 30, 2019 | Oct 01, 2019 | Oct 15, 2019 | 0.1200 |
2019 | Jan 30, 2019 | Feb 20, 2019 | Feb 21, 2019 | Mar 21, 2019 | 0.0600 |
2019 Total: | 0.1800 |